Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Hancock Whitney
HWC
$6.24B
| $4.2M | ﹤0.01% |
86,796
+20,732
| +31% | +$1.07M |
|
|
SKX
1727
CALL
DELISTED
Skechers
SKX
| $4.2M | ﹤0.01% |
100,000
| – | – |
|
1728
Chord Energy
CHRD
$7.39B
| $4.19M | ﹤0.01% |
30,645
+9,491
| +45% | +$1.39M |
|
|
JWAC
1729
DELISTED
Jupiter Wellness Acquisition Corp. Class A Common Stock
JWAC
| $4.18M | ﹤0.01% |
400,302
| – | – |
|
1730
PUT
SLB Ltd
SLB
$75B
| $4.18M | ﹤0.01% |
+78,200
| New | +$3.89M |
|
1731
SL Green Realty
SLG
$3.99B
| $4.17M | ﹤0.01% |
123,709
+90,075
| +268% | +$3.42M |
|
1732
Medpace
MEDP
$16.5B
| $4.17M | ﹤0.01% |
19,632
-6,460
| -25% | -$1.29M |
|
1733
Veracyte
VCYT
$3.8B
| $4.17M | ﹤0.01% |
175,599
-51,041
| -23% | -$1.19M |
|
1734
PBF Energy
PBF
$7.31B
| $4.14M | ﹤0.01% |
101,572
-98,287
| -49% | -$4.09M |
|
|
ZPTA
1735
DELISTED
Zapata Computing Holdings Inc. Common Stock
ZPTA
| $4.13M | ﹤0.01% |
400,000
| – | – |
|
1736
Park Hotels & Resorts
PK
$2.97B
| $4.13M | ﹤0.01% |
350,160
+8,190
| +2% | +$99.8K |
|
1737
PUT
Coinbase
COIN
$40.5B
| $4.13M | ﹤0.01% |
+116,600
| New | +$6.14M |
|
1738
Lantheus
LNTH
$6.59B
| $4.13M | ﹤0.01% |
80,972
+48,694
| +151% | +$3M |
|
|
AAIC
1739
DELISTED
Arlington Asset Investment Corp.
AAIC
| $4.12M | ﹤0.01% |
1,406,438
-15,000
| -1% | -$44.4K |
|
|
PGM
1740
DELISTED
iPath Series B Bloomberg Platinum Subindex Total ReturnSM ETN
PGM
| $4.12M | ﹤0.01% |
80,000
| – | – |
|
1741
Agnico Eagle Mines
AEM
$90.5B
| $4.12M | ﹤0.01% |
79,169
+18,245
| +30% | +$861K |
|
1742
Valens Semiconductor
VLN
$188M
| $4.09M | ﹤0.01% |
761,578
+634,671
| +500% | +$2.69M |
|
1743
COPT Defense Properties
CDP
$4.21B
| $4.09M | ﹤0.01% |
157,645
+33,279
| +27% | +$855K |
|
1744
MKS Inc
MKSI
$20.6B
| $4.07M | ﹤0.01% |
47,976
-57,411
| -54% | -$4.6M |
|
1745
Relay Therapeutics
RLAY
$4.33B
| $4.06M | ﹤0.01% |
271,839
+121,628
| +81% | +$2.33M |
|
1746
CALL
Beyond Meat
BYND
$277M
| $4.05M | ﹤0.01% |
+328,700
| New | +$4.58M |
|
1747
Borealis Foods
BRLS
$19.7M
| $4.04M | ﹤0.01% |
391,200
| – | – |
|
|
DVAX
1748
DELISTED
Dynavax Technologies
DVAX
| $4.03M | ﹤0.01% |
379,161
-18,340
| -5% | -$213K |
|
1749
Iovance Biotherapeutics
IOVA
$2.87B
| $4.03M | ﹤0.01% |
630,950
+240,344
| +62% | +$1.88M |
|
1750
Liberty Global Class C
LBTYK
$3.49B
| $4.03M | ﹤0.01% |
207,199
+41,873
| +25% | +$792K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.